Form D · Biotechnology
Genomics USA, Inc.
Tucson, AZ · CIK 0001577606
Offering snapshot reported Jun 11, 2013 · SEC filing
- Reported sold
- $837K Offering amount: $3.29M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 4, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 11, 2013 | Initial | $837,405 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-197800
Source: Form D, filed Jun 11, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Hogan | Director, Executive |
| Krishna Jayaraman | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3450 S Broadmont Drive Suite 104
Tucson, AZ, 85713
Tucson, AZ, 85713